Health Condition 1: C940- Acute erythroid leukemia Health Condition 2: C950- Acute leukemia of unspecified celltype Health Condition 3: C910- Acute lymphoblastic leukemia [ALL] Health Condition 4: C942- Acute megakaryoblastic leukemia Health Condition 5: C930- Acute monoblastic/monocytic leukemia Health Condition 6: C920- Acute myeloblastic leukemia
Conditions
Interventions
Intervention1: Not Applicable: Not Applicable
Control Intervention1: Not Applicable: Not Applicable
Sponsors
Not Applicable
Not Applicable
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion criteria: -Newly-diagnosed leukemia -Signed written informed consent -Age more than or equal to 15 years
Exclusion criteria
Exclusion criteria: None
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 3- Year overall survivalTimepoint: At 3 year | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Epidemiology 2.complete remission (CR) and CRm 3.Minimal residual disease negative status post therapy 4.Treatment related mortality (TRM) 5.Cumulative incidence of relapse (CIR) 6.Relapse free survival 7.Grade IV toxicities 8.Pattern of infections 9.Quality of life (QoL)assessmentTimepoint: 1.Epidemiology-5 year 2.complete remission (CR) and CRm-30 days 3.Minimal residual disease negative status post therapy-30 days 4.Treatment related mortality (TRM)-30 days 5.Cumulative incidence of relapse (CIR)-3 years 6.Relapse free survival-3 years 7.Grade IV toxicities-30 days 8.Pattern of infections-30 days 9.Quality of life (QoL)assessment- every year | — |
Countries
India
Contacts
Public ContactDr Manju Sengar
Tata Memorial Centre
Outcome results
None listed